Integrin AvB6 inhibiting Peptide

a major new target for molecular-specific imaging and therapy of cancer. This peptide could not only permit diagnostic imaging, but also deliver anticancer therapy specifically to tumour cells while sparing local normal tissues.

Contributors

Inventor Institute
John Marshall Queen Mary University of London
Cat. #: 151860
Tool sub type: Inhibitor
Research Fields: Cancer;Cell biology
Product description: av?6 is a major new target for molecular-specific imaging and therapy of cancer. It is expressed only on epithelia and then usually only during processes of tissue remodelling; these include wound healing, chronic inflammation, and cancer. The av?6 inhibiting peptide could not only permit diagnostic imaging, but also to deliver anticancer therapy specifically to tumour cells while sparing local normal tissues.
Function: Inhibitor
Animal free: Yes
References:

Saha et al. 2010. J Pathol. 222(1):52-63. PMID: 20629113.

High-resolution in vivo imaging of breast cancer by targeting the pro-invasive integrin alphavbeta6.

Related Tools for Proteins

Cat. # Tool Name
154132 CHEC-7 immunomodulatory Peptide Key Info View Tool
156500 a1-ORD Protein Key Info View Tool
157646 NF70 peptide Key Info View Tool
157647 NF71 peptide Key Info View Tool
157650 NF704 peptide Key Info View Tool

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.